Jauch W, Kurnik PB, Hanlon SJ, Siegel JE, Matthai WH. Expected hemoglobin decrease following percutaneous transluminal coronary angioplasty.
Am J Cardiol 1997;
80:71-4. [PMID:
9205023 DOI:
10.1016/s0002-9149(97)90146-6]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
To establish expected changes in hemoglobin during and after percutaneous transluminal coronary angioplasty (PTCA), we measured hemoglobin before, at the end of, and on the 2 mornings after PTCA in 177 consecutive patients without obvious out-of-laboratory blood loss. From these data, we calculated confidence intervals that can be used to compare group data, possibly to identify excessive blood loss with new devices or antithrombotic agents, and prediction intervals to identify unexpected blood loss in an individual patient.
Collapse